Last C$0.46 CAD
Change Today 0.00 / 0.00%
Volume 248.2K
LOR On Other Exchanges
Symbol
Exchange
Toronto
OTC US
Frankfurt
As of 3:59 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

lorus therapeutics inc (LOR) Snapshot

Open
C$0.50
Previous Close
C$0.46
Day High
C$0.50
Day Low
C$0.46
52 Week High
11/7/13 - C$1.04
52 Week Low
07/19/13 - C$0.17
Market Cap
57.3M
Average Volume 10 Days
210.0K
EPS TTM
--
Shares Outstanding
124.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LORUS THERAPEUTICS INC (LOR)

Related News

No related news articles were found.

lorus therapeutics inc (LOR) Related Businessweek News

No Related Businessweek News Found

lorus therapeutics inc (LOR) Details

Lorus Therapeutics Inc., a biopharmaceutical company, engages in the discovery, research, and development of novel anticancer therapies in Canada. Its product pipeline includes LOR-253, an anticancer agent for the treatment of human cancers, including colon cancer and non-small cell lung cancer; IL-17E, an immunotherapy for various solid tumors, including human melanoma, pancreatic, colon, lung, ovarian, and breast tumor; and LOR-500 program to discover and develop potent and small molecule inhibitors of maternal embryonic leucine zipper kinase. The company’s development stage products also include LOR-2040, an antisense ribonucleotide reductase (R2) synthesis inhibitor for the treatment of acute myeloid leukemia; and Virulizin for various cancers, including breast, ovarian, and pancreatic cancers. In addition, its preclinical stage small molecules comprise LOR-220, a novel small molecule for drug-resistant bacterial infections. The company was formerly known as Imutec Pharma Inc. and changed its name to Lorus Therapeutics Inc. in November 1998. Lorus Therapeutics Inc. was founded in 1986 and is headquartered in Toronto, Canada.

15 Employees
Last Reported Date: 07/16/13
Founded in 1986

lorus therapeutics inc (LOR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lorus therapeutics inc (LOR) Key Developments

Lorus Therapeutics Inc. Presents at Bloom Burton & Co. Healthcare Investor Conference, Jun-18-2014 10:30 AM

Lorus Therapeutics Inc. Presents at Bloom Burton & Co. Healthcare Investor Conference, Jun-18-2014 10:30 AM. Venue: Toronto Board of Trade, 1 First Canadian Place (Corner of Bay and Adelaide), Toronto, ON M5X 1C1, Canada. Speakers: William G. Rice, Chairman, Chief Executive Officer and President.

Lorus Therapeutics Inc. Presents at JMP Securities Healthcare Conference, Jun-25-2014 12:00 PM

Lorus Therapeutics Inc. Presents at JMP Securities Healthcare Conference, Jun-25-2014 12:00 PM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States. Speakers: William G. Rice, Chairman, Chief Executive Officer and President.

Lorus Therapeutics Inc. Reports Unaudited Consolidated Cash Flow Results for the Three and Nine Months Ended February 28, 2014

Lorus Therapeutics Inc. reported unaudited consolidated cash flow results for the three and nine months ended February 28, 2014. For the three months the company reported cash used in operating activities of CAD 2,191,000 against CAD 1,273,000 a year ago. Purchase of fixed assets was CAD 5,000. For the nine months the company reported cash used in operating activities of CAD 4,607,000 against CAD 4,186,000 a year ago. Purchase of fixed assets was CAD 8,000.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LOR:CN C$0.46 CAD 0.00

LOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LOR.
View Industry Companies
 

Industry Analysis

LOR

Industry Average

Valuation LOR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 7.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LORUS THERAPEUTICS INC, please visit www.lorusthera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.